Calvert BioCapital

Calvert BioCapital was a venture capital firm based in Cary, North Carolina, specializing in the life sciences and healthcare sectors. Founded in 2007 by Russ C. McLauchlan as an affiliate of Calvert Holdings, the firm focused on an alternative investment model that involved acquiring rights to early-stage pharmaceutical components and medical devices. It worked in tandem with sister companies Calvert Laboratories, a preclinical CRO, and Calvert Research to identify and advance promising therapeutic candidates. Notable investments included companies such as Oncoceutics and CureDM, focusing on oncology and metabolic diseases. The firm is currently inactive following the wind-down of its funds and the 2021 acquisition of Calvert Laboratories by Altasciences.